What laboratory tests should be ordered to evaluate anemia?

Laboratory Evaluation of Anemia

Order a complete blood count (CBC) with hemoglobin, white blood cell count, and platelet count as the foundational panel, followed by reticulocyte count and iron studies (serum ferritin and transferrin saturation) to classify and determine the cause of anemia. 1

Core Initial Laboratory Tests

• Hemoglobin measurement is superior to hematocrit because it demonstrates better inter-laboratory reproducibility, lower coefficient of variation, and remains unaffected by sample storage time or serum glucose levels 2, 1

• CBC with differential must include white blood cell count and platelet count to assess overall bone marrow function—abnormalities in two or more cell lines warrant hematology consultation for possible marrow pathology 2, 1

• Mean corpuscular volume (MCV) directs the diagnostic pathway: low MCV (<80 fL) suggests iron, folate, or vitamin B12 deficiency or inherited hemoglobin synthesis disorders; normocytic (80-100 fL) suggests chronic disease, hemolysis, or marrow disorders; macrocytic (>100 fL) requires vitamin B12, folate, and thyroid function testing 2, 1, 3

Reticulocyte Assessment

• Reticulocyte count (absolute or reticulocyte index adjusted for anemia severity) evaluates bone marrow response adequacy and distinguishes between production defects versus increased destruction or blood loss 2, 1

• Low reticulocyte count indicates inadequate marrow output from absent iron, intrinsic red cell production defects, insufficient erythropoietin (especially in CKD), or inflammatory inhibition 2, 1

• Elevated reticulocyte count signals hemolysis or acute blood loss and should prompt evaluation with lactate dehydrogenase, haptoglobin, bilirubin, and peripheral blood smear 3, 4

Iron Studies: Interpretation and Pitfalls

• Serum ferritin serves as the surrogate marker for tissue iron stores and is essential in the initial iron panel 2, 1

• Ferritin thresholds vary by population: in non-dialysis CKD patients, use <25 ng/mL (males) or <11 ng/mL (females) to predict insufficient iron stores; in the general population, use <45 ng/mL when clinical context supports iron deficiency 2, 1

• Ferritin is an acute-phase reactant and falsely elevated in inflammation, CKD, or chronic disease—do not rely on ferritin alone in these settings 1

• Transferrin saturation (TSAT) reflects iron immediately available for erythropoiesis and is less influenced by inflammation, making it more reliable than ferritin in CKD and inflammatory states 2, 1

Additional Testing Based on Clinical Context

• Peripheral blood smear provides morphologic clues when the diagnosis remains unclear after CBC and reticulocyte count, revealing characteristic red cell abnormalities for specific anemias 3, 4

• In iron deficiency without obvious blood loss (excluding menstrual loss), evaluate for gastrointestinal bleeding: perform non-invasive testing for Helicobacter pylori and celiac disease first, then proceed to bidirectional endoscopy (upper and lower) in men and post-menopausal women 1

• Vitamin B12 and folate levels are indicated for macrocytic anemia (MCV >100 fL), along with thyroid function testing 3, 5

• Hemoglobin electrophoresis is warranted for microcytic anemia unresponsive to iron therapy or when thalassemia is suspected, particularly in patients of Mediterranean, African, or Southeast Asian descent 2

Common Pitfalls to Avoid

• Never interpret ferritin in isolation in CKD, chronic disease, or inflammatory conditions—always use TSAT as the primary marker of iron availability in these populations 1

• Do not assume CKD is the sole cause of anemia in kidney disease patients—the anemia of CKD is normochromic and normocytic, indistinguishable from other chronic conditions, requiring full evaluation 2

• In non-dialysis CKD patients on erythropoiesis-stimulating agents who develop iron deficiency, search for gastrointestinal bleeding as the most likely occult source 2, 1

• Recognize that normal or low reticulocyte count in the setting of anemia is always abnormal—the marrow should respond with increased reticulocyte production unless erythropoietin is deficient, iron is unavailable, or inflammation/marrow pathology is present 2, 1